GO:0016363 | nuclear matrix | 1.36e-06 | 1.33e-02 | 5.479 | 4 | 7 | 73 |
GO:0005654 | nucleoplasm | 2.42e-05 | 2.36e-01 | 2.701 | 7 | 55 | 876 |
GO:0000812 | Swr1 complex | 2.90e-05 | 2.83e-01 | 7.861 | 2 | 2 | 7 |
GO:0031011 | Ino80 complex | 3.86e-05 | 3.77e-01 | 7.668 | 2 | 2 | 8 |
GO:0043968 | histone H2A acetylation | 6.20e-05 | 6.05e-01 | 7.347 | 2 | 2 | 10 |
GO:0035267 | NuA4 histone acetyltransferase complex | 9.08e-05 | 8.86e-01 | 7.083 | 2 | 3 | 12 |
GO:0070062 | extracellular vesicular exosome | 1.63e-04 | 1.00e+00 | 1.988 | 8 | 43 | 1641 |
GO:0005839 | proteasome core complex | 1.65e-04 | 1.00e+00 | 6.668 | 2 | 9 | 16 |
GO:0004298 | threonine-type endopeptidase activity | 1.86e-04 | 1.00e+00 | 6.581 | 2 | 9 | 17 |
GO:0016020 | membrane | 1.95e-04 | 1.00e+00 | 2.239 | 7 | 38 | 1207 |
GO:0005730 | nucleolus | 2.06e-04 | 1.00e+00 | 2.227 | 7 | 41 | 1217 |
GO:0003678 | DNA helicase activity | 2.10e-04 | 1.00e+00 | 6.499 | 2 | 3 | 18 |
GO:0071339 | MLL1 complex | 2.10e-04 | 1.00e+00 | 6.499 | 2 | 2 | 18 |
GO:0010467 | gene expression | 2.78e-04 | 1.00e+00 | 2.927 | 5 | 31 | 535 |
GO:0043967 | histone H4 acetylation | 3.15e-04 | 1.00e+00 | 6.209 | 2 | 2 | 22 |
GO:0000398 | mRNA splicing, via spliceosome | 4.44e-04 | 1.00e+00 | 4.253 | 3 | 8 | 128 |
GO:0005634 | nucleus | 5.26e-04 | 1.00e+00 | 1.326 | 10 | 67 | 3246 |
GO:0015030 | Cajal body | 6.73e-04 | 1.00e+00 | 5.668 | 2 | 2 | 32 |
GO:0040008 | regulation of growth | 9.00e-04 | 1.00e+00 | 5.459 | 2 | 2 | 37 |
GO:0008380 | RNA splicing | 9.32e-04 | 1.00e+00 | 3.887 | 3 | 7 | 165 |
GO:0032508 | DNA duplex unwinding | 9.50e-04 | 1.00e+00 | 5.421 | 2 | 5 | 38 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.11e-03 | 1.00e+00 | 5.311 | 2 | 16 | 41 |
GO:1990259 | histone-glutamine methyltransferase activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:1990258 | histone glutamine methylation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0016074 | snoRNA metabolic process | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 1 |
GO:0000502 | proteasome complex | 1.45e-03 | 1.00e+00 | 5.114 | 2 | 17 | 47 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.58e-03 | 1.00e+00 | 5.054 | 2 | 3 | 49 |
GO:0006310 | DNA recombination | 1.64e-03 | 1.00e+00 | 5.025 | 2 | 6 | 50 |
GO:0006281 | DNA repair | 1.70e-03 | 1.00e+00 | 3.588 | 3 | 19 | 203 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.77e-03 | 1.00e+00 | 4.968 | 2 | 17 | 52 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.84e-03 | 1.00e+00 | 4.941 | 2 | 17 | 53 |
GO:0043234 | protein complex | 1.87e-03 | 1.00e+00 | 3.539 | 3 | 8 | 210 |
GO:0005681 | spliceosomal complex | 1.98e-03 | 1.00e+00 | 4.887 | 2 | 2 | 55 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.05e-03 | 1.00e+00 | 4.861 | 2 | 17 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.13e-03 | 1.00e+00 | 4.836 | 2 | 16 | 57 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.36e-03 | 1.00e+00 | 4.762 | 2 | 17 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 2.43e-03 | 1.00e+00 | 4.738 | 2 | 5 | 61 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.43e-03 | 1.00e+00 | 4.738 | 2 | 16 | 61 |
GO:0072070 | loop of Henle development | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0001757 | somite specification | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0072014 | proximal tubule development | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 2 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.76e-03 | 1.00e+00 | 4.646 | 2 | 17 | 65 |
GO:0006325 | chromatin organization | 3.19e-03 | 1.00e+00 | 4.539 | 2 | 3 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.19e-03 | 1.00e+00 | 4.539 | 2 | 16 | 70 |
GO:0001649 | osteoblast differentiation | 3.56e-03 | 1.00e+00 | 4.459 | 2 | 2 | 74 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0007386 | compartment pattern specification | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0001652 | granular component | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0031428 | box C/D snoRNP complex | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 3 |
GO:0030529 | ribonucleoprotein complex | 4.35e-03 | 1.00e+00 | 4.311 | 2 | 4 | 82 |
GO:0005515 | protein binding | 4.51e-03 | 1.00e+00 | 0.981 | 10 | 76 | 4124 |
GO:0051414 | response to cortisol | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0071169 | establishment of protein localization to chromatin | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 4 |
GO:0000209 | protein polyubiquitination | 5.45e-03 | 1.00e+00 | 4.145 | 2 | 16 | 92 |
GO:0000278 | mitotic cell cycle | 5.84e-03 | 1.00e+00 | 2.959 | 3 | 35 | 314 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0014075 | response to amine | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 5 |
GO:0016887 | ATPase activity | 6.41e-03 | 1.00e+00 | 4.025 | 2 | 6 | 100 |
GO:0034641 | cellular nitrogen compound metabolic process | 7.05e-03 | 1.00e+00 | 3.954 | 2 | 18 | 105 |
GO:0001055 | RNA polymerase II activity | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 6 |
GO:0042981 | regulation of apoptotic process | 7.98e-03 | 1.00e+00 | 3.861 | 2 | 18 | 112 |
GO:0042802 | identical protein binding | 8.14e-03 | 1.00e+00 | 2.786 | 3 | 7 | 354 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 7 |
GO:0003924 | GTPase activity | 8.97e-03 | 1.00e+00 | 3.774 | 2 | 3 | 119 |
GO:0031122 | cytoplasmic microtubule organization | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 2 | 8 |
GO:0032693 | negative regulation of interleukin-10 production | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 8 |
GO:0000082 | G1/S transition of mitotic cell cycle | 9.87e-03 | 1.00e+00 | 3.703 | 2 | 24 | 125 |
GO:0006184 | GTP catabolic process | 1.06e-02 | 1.00e+00 | 3.646 | 2 | 3 | 130 |
GO:0070986 | left/right axis specification | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0008266 | poly(U) RNA binding | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 10 |
GO:0006541 | glutamine metabolic process | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0005112 | Notch binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 10 |
GO:0005829 | cytosol | 1.26e-02 | 1.00e+00 | 1.450 | 6 | 58 | 1787 |
GO:0007020 | microtubule nucleation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 11 |
GO:0001709 | cell fate determination | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0097150 | neuronal stem cell maintenance | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 11 |
GO:0016032 | viral process | 1.37e-02 | 1.00e+00 | 2.512 | 3 | 32 | 428 |
GO:0071392 | cellular response to estradiol stimulus | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 13 |
GO:0001056 | RNA polymerase III activity | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 13 |
GO:0035066 | positive regulation of histone acetylation | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0060749 | mammary gland alveolus development | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 14 |
GO:0010243 | response to organonitrogen compound | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 14 |
GO:0016071 | mRNA metabolic process | 1.77e-02 | 1.00e+00 | 3.259 | 2 | 21 | 170 |
GO:0045638 | negative regulation of myeloid cell differentiation | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 15 |
GO:0007220 | Notch receptor processing | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 16 |
GO:0005719 | nuclear euchromatin | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 16 |
GO:0006206 | pyrimidine nucleobase metabolic process | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 2 | 17 |
GO:0016070 | RNA metabolic process | 2.14e-02 | 1.00e+00 | 3.114 | 2 | 21 | 188 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 18 |
GO:0045747 | positive regulation of Notch signaling pathway | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 18 |
GO:0033574 | response to testosterone | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 18 |
GO:0000794 | condensed nuclear chromosome | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 3 | 18 |
GO:0005525 | GTP binding | 2.34e-02 | 1.00e+00 | 3.046 | 2 | 5 | 197 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 20 |
GO:0017144 | drug metabolic process | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 21 |
GO:0030331 | estrogen receptor binding | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 22 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 24 |
GO:0048839 | inner ear development | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 24 |
GO:0004003 | ATP-dependent DNA helicase activity | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 25 |
GO:0008033 | tRNA processing | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 25 |
GO:0007368 | determination of left/right symmetry | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 1 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 27 |
GO:0034644 | cellular response to UV | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 28 |
GO:0030155 | regulation of cell adhesion | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 1 | 28 |
GO:0018107 | peptidyl-threonine phosphorylation | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 2 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 2 | 29 |
GO:0003723 | RNA binding | 3.56e-02 | 1.00e+00 | 2.720 | 2 | 11 | 247 |
GO:0043195 | terminal bouton | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 1 | 31 |
GO:0031490 | chromatin DNA binding | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 1 | 31 |
GO:0007595 | lactation | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 2 | 32 |
GO:0014070 | response to organic cyclic compound | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 34 |
GO:0001947 | heart looping | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 2 | 36 |
GO:0035690 | cellular response to drug | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 2 | 38 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 6 | 40 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 40 |
GO:0042995 | cell projection | 4.93e-02 | 1.00e+00 | 4.311 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 4.93e-02 | 1.00e+00 | 4.311 | 1 | 9 | 41 |
GO:0031100 | organ regeneration | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 2 | 44 |
GO:0032481 | positive regulation of type I interferon production | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 5 | 48 |
GO:0030097 | hemopoiesis | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 3 | 48 |
GO:0043066 | negative regulation of apoptotic process | 5.75e-02 | 1.00e+00 | 2.338 | 2 | 20 | 322 |
GO:0006334 | nucleosome assembly | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 5 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 3 | 52 |
GO:0006289 | nucleotide-excision repair | 6.33e-02 | 1.00e+00 | 3.941 | 1 | 9 | 53 |
GO:0006338 | chromatin remodeling | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 2 | 55 |
GO:0044822 | poly(A) RNA binding | 6.88e-02 | 1.00e+00 | 1.611 | 3 | 25 | 799 |
GO:0007565 | female pregnancy | 7.59e-02 | 1.00e+00 | 3.668 | 1 | 2 | 64 |
GO:0044281 | small molecule metabolic process | 7.85e-02 | 1.00e+00 | 1.532 | 3 | 32 | 844 |
GO:0006364 | rRNA processing | 7.93e-02 | 1.00e+00 | 3.602 | 1 | 4 | 67 |
GO:0005200 | structural constituent of cytoskeleton | 8.05e-02 | 1.00e+00 | 3.581 | 1 | 2 | 68 |
GO:0051082 | unfolded protein binding | 8.28e-02 | 1.00e+00 | 3.539 | 1 | 4 | 70 |
GO:0001889 | liver development | 8.39e-02 | 1.00e+00 | 3.519 | 1 | 1 | 71 |
GO:0031410 | cytoplasmic vesicle | 8.73e-02 | 1.00e+00 | 3.459 | 1 | 1 | 74 |
GO:0006915 | apoptotic process | 8.83e-02 | 1.00e+00 | 1.985 | 2 | 21 | 411 |
GO:0005524 | ATP binding | 8.96e-02 | 1.00e+00 | 1.453 | 3 | 23 | 892 |
GO:0005815 | microtubule organizing center | 9.07e-02 | 1.00e+00 | 3.402 | 1 | 1 | 77 |
GO:0007219 | Notch signaling pathway | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 4 | 95 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.13e-01 | 1.00e+00 | 3.069 | 1 | 5 | 97 |
GO:0006457 | protein folding | 1.13e-01 | 1.00e+00 | 3.069 | 1 | 4 | 97 |
GO:0007507 | heart development | 1.23e-01 | 1.00e+00 | 2.941 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 1.23e-01 | 1.00e+00 | 2.941 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 1.26e-01 | 1.00e+00 | 2.900 | 1 | 3 | 109 |
GO:0006397 | mRNA processing | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 2 | 110 |
GO:0006351 | transcription, DNA-templated | 1.38e-01 | 1.00e+00 | 1.182 | 3 | 9 | 1076 |
GO:0016607 | nuclear speck | 1.40e-01 | 1.00e+00 | 2.738 | 1 | 3 | 122 |
GO:0004672 | protein kinase activity | 1.43e-01 | 1.00e+00 | 2.703 | 1 | 2 | 125 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.61e-01 | 1.00e+00 | 2.519 | 1 | 2 | 142 |
GO:0005622 | intracellular | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 1 | 145 |
GO:0007267 | cell-cell signaling | 1.68e-01 | 1.00e+00 | 2.459 | 1 | 1 | 148 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.81e-01 | 1.00e+00 | 2.338 | 1 | 4 | 161 |
GO:0007067 | mitotic nuclear division | 1.85e-01 | 1.00e+00 | 2.302 | 1 | 8 | 165 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.85e-01 | 1.00e+00 | 1.338 | 2 | 8 | 644 |
GO:0007283 | spermatogenesis | 1.88e-01 | 1.00e+00 | 2.276 | 1 | 2 | 168 |
GO:0043025 | neuronal cell body | 1.91e-01 | 1.00e+00 | 2.251 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 1.96e-01 | 1.00e+00 | 2.209 | 1 | 6 | 176 |
GO:0005743 | mitochondrial inner membrane | 2.17e-01 | 1.00e+00 | 2.046 | 1 | 3 | 197 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.23e-01 | 1.00e+00 | 2.003 | 1 | 1 | 203 |
GO:0030154 | cell differentiation | 2.24e-01 | 1.00e+00 | 1.996 | 1 | 3 | 204 |
GO:0019899 | enzyme binding | 2.30e-01 | 1.00e+00 | 1.954 | 1 | 4 | 210 |
GO:0005813 | centrosome | 2.36e-01 | 1.00e+00 | 1.907 | 1 | 8 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 2.37e-01 | 1.00e+00 | 1.900 | 1 | 7 | 218 |
GO:0006200 | ATP catabolic process | 2.38e-01 | 1.00e+00 | 1.894 | 1 | 8 | 219 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.27e-01 | 1.00e+00 | 1.360 | 1 | 7 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.47e-01 | 1.00e+00 | 1.255 | 1 | 6 | 341 |
GO:0005509 | calcium ion binding | 3.56e-01 | 1.00e+00 | 1.213 | 1 | 3 | 351 |
GO:0005794 | Golgi apparatus | 4.06e-01 | 1.00e+00 | 0.971 | 1 | 5 | 415 |
GO:0005737 | cytoplasm | 4.13e-01 | 1.00e+00 | 0.306 | 4 | 50 | 2633 |
GO:0045087 | innate immune response | 4.34e-01 | 1.00e+00 | 0.848 | 1 | 7 | 452 |
GO:0005887 | integral component of plasma membrane | 5.17e-01 | 1.00e+00 | 0.501 | 1 | 2 | 575 |
GO:0005739 | mitochondrion | 5.68e-01 | 1.00e+00 | 0.304 | 1 | 11 | 659 |
GO:0005576 | extracellular region | 5.70e-01 | 1.00e+00 | 0.296 | 1 | 5 | 663 |
GO:0008270 | zinc ion binding | 6.05e-01 | 1.00e+00 | 0.163 | 1 | 7 | 727 |
GO:0003677 | DNA binding | 7.06e-01 | 1.00e+00 | -0.219 | 1 | 18 | 947 |
GO:0005886 | plasma membrane | 9.11e-01 | 1.00e+00 | -1.132 | 1 | 11 | 1784 |